Where it may be relevant
- Non-immune adults and children for whom private vaccination is appropriate
- People with close contacts at higher risk of severe chickenpox after clinical review
- Travellers or workers needing evidence-based protection
Dose schedules.
The clinician will select the appropriate licensed schedule after reviewing age, health, previous doses and departure date.
Two-dose course
Eligible adults and children
The minimum interval depends on age and product.
Who may be eligible
- People from the selected product's licensed age without reliable evidence of immunity
- Those able to avoid pregnancy for the period specified after this live vaccine
Who may not be eligible
- Anyone with a confirmed severe allergic reaction to a previous dose or a vaccine ingredient
- People who are acutely unwell with a significant fever may need vaccination deferred
- Pregnancy, breastfeeding, immune suppression and current medicines must be reviewed individually
- Pregnancy and significant immune suppression are contraindications to this live vaccine
- Recent blood products and some antiviral medicines may affect timing
Potential side effects
- Pain, redness or swelling where the injection is given
- Headache, tiredness, muscle aches or a mild fever
- Feeling faint around the time of vaccination
Important risks and precautions
- A severe allergic reaction is very rare and requires urgent treatment
- Protection is not absolute, so relevant food, water, bite or exposure precautions remain important
- The exact product and schedule must be confirmed during a clinical assessment
- A mild vaccine-related rash can occur; contact with highly vulnerable people may need to be avoided if this develops
Clinical references
Further information.
Information is general and does not replace a personal assessment, prescribing decision or the latest destination-specific advice.
